Interference from digoxin-like immunoreactive substance(s) in commercial digoxin kit assay methods

R. G. Morris, D. B. Frewin, N. C. Saccoia, W. L. Goldsworthy, W. S. Jeffries, Andrew McPhee

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

We have examined the current state of interference by digoxin-like immunoreactive substance(s) (DLIS) in 10 commercially available digoxin assay methods, ie 5 radioimmunoassays (RIA) and 5 non-radioactive immunoassays. Fifty-five specimens of maternal venous blood (30 from third trimester pregnancy and 25 at delivery) and 32 cord samples from their offspring were tested (none of the subjects being medicated with digoxin). The results demonstrated a wide range of DLIS interference with values up to 1.1 μg·l-1 being obtained in the cord blood specimens. Of the methods tested the "Coat-a Count" RIA (Diagnostic Products Corporation) and the EMIT column method (Syva) run on the Cobas MIRA (Roche) consistently showed the least interference with respect to all 3 sources of specimens. The Delfia Method (LKB/Wallac) consistently showed the greatest crossreactivity with DLIS. The present study thus demonstrates that DLIS interference persists in several commercial digoxin methods and suggests that the use of data obtained from such methods may compromise patient management.

LanguageEnglish
Pages359-363
Number of pages5
JournalEuropean Journal of Clinical Pharmacology
Volume39
Issue number4
DOIs
Publication statusPublished - 1 Oct 1990
Externally publishedYes

Keywords

  • analytical interference
  • digoxin
  • immunoassay
  • therapeutic drug monitoring

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Morris, R. G. ; Frewin, D. B. ; Saccoia, N. C. ; Goldsworthy, W. L. ; Jeffries, W. S. ; McPhee, Andrew. / Interference from digoxin-like immunoreactive substance(s) in commercial digoxin kit assay methods. In: European Journal of Clinical Pharmacology. 1990 ; Vol. 39, No. 4. pp. 359-363.
@article{a99782aea0754e97b12679e2bc1f755a,
title = "Interference from digoxin-like immunoreactive substance(s) in commercial digoxin kit assay methods",
abstract = "We have examined the current state of interference by digoxin-like immunoreactive substance(s) (DLIS) in 10 commercially available digoxin assay methods, ie 5 radioimmunoassays (RIA) and 5 non-radioactive immunoassays. Fifty-five specimens of maternal venous blood (30 from third trimester pregnancy and 25 at delivery) and 32 cord samples from their offspring were tested (none of the subjects being medicated with digoxin). The results demonstrated a wide range of DLIS interference with values up to 1.1 μg·l-1 being obtained in the cord blood specimens. Of the methods tested the {"}Coat-a Count{"} RIA (Diagnostic Products Corporation) and the EMIT column method (Syva) run on the Cobas MIRA (Roche) consistently showed the least interference with respect to all 3 sources of specimens. The Delfia Method (LKB/Wallac) consistently showed the greatest crossreactivity with DLIS. The present study thus demonstrates that DLIS interference persists in several commercial digoxin methods and suggests that the use of data obtained from such methods may compromise patient management.",
keywords = "analytical interference, digoxin, immunoassay, therapeutic drug monitoring",
author = "Morris, {R. G.} and Frewin, {D. B.} and Saccoia, {N. C.} and Goldsworthy, {W. L.} and Jeffries, {W. S.} and Andrew McPhee",
year = "1990",
month = "10",
day = "1",
doi = "10.1007/BF00315410",
language = "English",
volume = "39",
pages = "359--363",
journal = "European Journal of Clinical Pharmacology",
issn = "0031-6970",
publisher = "Springer Verlag",
number = "4",

}

Interference from digoxin-like immunoreactive substance(s) in commercial digoxin kit assay methods. / Morris, R. G.; Frewin, D. B.; Saccoia, N. C.; Goldsworthy, W. L.; Jeffries, W. S.; McPhee, Andrew.

In: European Journal of Clinical Pharmacology, Vol. 39, No. 4, 01.10.1990, p. 359-363.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Interference from digoxin-like immunoreactive substance(s) in commercial digoxin kit assay methods

AU - Morris, R. G.

AU - Frewin, D. B.

AU - Saccoia, N. C.

AU - Goldsworthy, W. L.

AU - Jeffries, W. S.

AU - McPhee, Andrew

PY - 1990/10/1

Y1 - 1990/10/1

N2 - We have examined the current state of interference by digoxin-like immunoreactive substance(s) (DLIS) in 10 commercially available digoxin assay methods, ie 5 radioimmunoassays (RIA) and 5 non-radioactive immunoassays. Fifty-five specimens of maternal venous blood (30 from third trimester pregnancy and 25 at delivery) and 32 cord samples from their offspring were tested (none of the subjects being medicated with digoxin). The results demonstrated a wide range of DLIS interference with values up to 1.1 μg·l-1 being obtained in the cord blood specimens. Of the methods tested the "Coat-a Count" RIA (Diagnostic Products Corporation) and the EMIT column method (Syva) run on the Cobas MIRA (Roche) consistently showed the least interference with respect to all 3 sources of specimens. The Delfia Method (LKB/Wallac) consistently showed the greatest crossreactivity with DLIS. The present study thus demonstrates that DLIS interference persists in several commercial digoxin methods and suggests that the use of data obtained from such methods may compromise patient management.

AB - We have examined the current state of interference by digoxin-like immunoreactive substance(s) (DLIS) in 10 commercially available digoxin assay methods, ie 5 radioimmunoassays (RIA) and 5 non-radioactive immunoassays. Fifty-five specimens of maternal venous blood (30 from third trimester pregnancy and 25 at delivery) and 32 cord samples from their offspring were tested (none of the subjects being medicated with digoxin). The results demonstrated a wide range of DLIS interference with values up to 1.1 μg·l-1 being obtained in the cord blood specimens. Of the methods tested the "Coat-a Count" RIA (Diagnostic Products Corporation) and the EMIT column method (Syva) run on the Cobas MIRA (Roche) consistently showed the least interference with respect to all 3 sources of specimens. The Delfia Method (LKB/Wallac) consistently showed the greatest crossreactivity with DLIS. The present study thus demonstrates that DLIS interference persists in several commercial digoxin methods and suggests that the use of data obtained from such methods may compromise patient management.

KW - analytical interference

KW - digoxin

KW - immunoassay

KW - therapeutic drug monitoring

UR - http://www.scopus.com/inward/record.url?scp=0025052355&partnerID=8YFLogxK

U2 - 10.1007/BF00315410

DO - 10.1007/BF00315410

M3 - Article

VL - 39

SP - 359

EP - 363

JO - European Journal of Clinical Pharmacology

T2 - European Journal of Clinical Pharmacology

JF - European Journal of Clinical Pharmacology

SN - 0031-6970

IS - 4

ER -